Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer
- PMID: 17967305
- DOI: 10.1016/j.ijrobp.2007.04.075
Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer
Abstract
Purpose: To describe dose-volume values with the use of water alone vs. a rectal balloon (RB) for the treatment of prostate cancer with proton therapy.
Materials and methods: We analyzed 30 proton plans for 15 patients who underwent CT and MRI scans with an RB or water alone. Simulation was performed with a modified MRI endorectal coil and an RB with 100 mL of water or water alone. Doses of 78-82 gray equivalents were prescribed to the planning target volume. The two groups were compared for three structures: rectum, rectal wall (RW), and rectal wall 7 cm (RW7) at the level of the planning target volume.
Results: Rectum and RW volumes radiated to low, intermediate, and high doses were small: rectum V10, 33.7%; V50, 17.3%; and V70, 10.2%; RW V10, 32.4%; V50, 20.4%; and V70, 14.6%. The RB effectively increased the rectal volume for all cases (139.8 +/- 44.9 mL vs. 217.7 +/- 32.2 mL (p < 0.001). The RB also decreased the volume of the rectum radiated to doses V10-V65 (p < or = 0.05); RW for V10-V50; and RW7 for V10-V35. An absolute rectum V50 improvement >5% was seen for the RB in 5 of 15 cases, for a benefit of 9.2% +/- 2.3% compared with 2.4% +/- 1.3% for the remaining 10 cases (p < 0.001). Similar benefit was seen for the rectal wall. No benefit was seen for doses > or =70 gray equivalents for the rectum, RW, or RW7. No benefit of < or =1% was seen with an RB in 46% for the rectum V70 and in 40% for the rectal wall V70.
Conclusions: Rectum and rectal wall doses with proton radiation were low whether using water or an RB. Selected patients will have a small but significant advantage with an RB; however, water alone was well tolerated and will be an alternative for most patients.
Similar articles
-
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. doi: 10.1016/j.ijrobp.2004.12.052. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029785 Review.
-
Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):141-9. doi: 10.1016/j.ijrobp.2004.12.017. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111582 Clinical Trial.
-
Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51. doi: 10.1016/j.ijrobp.2007.07.2335. Epub 2007 Sep 27. Int J Radiat Oncol Biol Phys. 2008. PMID: 17904306 Clinical Trial.
-
A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.Radiother Oncol. 2008 Jul;88(1):61-6. doi: 10.1016/j.radonc.2008.03.023. Epub 2008 Apr 29. Radiother Oncol. 2008. PMID: 18453021 Clinical Trial.
-
When should the seminal vesicles be included in the target volume in prostate radiotherapy?Clin Oncol (R Coll Radiol). 2007 Jun;19(5):302-7. doi: 10.1016/j.clon.2007.03.005. Epub 2007 Apr 19. Clin Oncol (R Coll Radiol). 2007. PMID: 17448647 Review.
Cited by
-
Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.Front Oncol. 2022 Mar 9;12:806153. doi: 10.3389/fonc.2022.806153. eCollection 2022. Front Oncol. 2022. PMID: 35356213 Free PMC article. Review.
-
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer.Adv Radiat Oncol. 2018 Feb 23;3(3):322-330. doi: 10.1016/j.adro.2018.02.004. eCollection 2018 Jul-Sep. Adv Radiat Oncol. 2018. PMID: 30202801 Free PMC article.
-
Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy.J Appl Clin Med Phys. 2012 Sep 6;13(5):3945. doi: 10.1120/jacmp.v13i5.3945. J Appl Clin Med Phys. 2012. PMID: 22955660 Free PMC article.
-
Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study.Curr Oncol. 2023 Jan 6;30(1):758-768. doi: 10.3390/curroncol30010058. Curr Oncol. 2023. PMID: 36661707 Free PMC article.
-
Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer.J Appl Clin Med Phys. 2017 May;18(3):37-43. doi: 10.1002/acm2.12063. Epub 2017 Apr 13. J Appl Clin Med Phys. 2017. PMID: 28407345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical